866-997-4948(US-Canada Toll Free)

EMEA (Europe, Middle East and Africa) Therapeutic Drug Monitoring Market Report 2017

Published By :

QYResearch

Published Date : Jul 2017

Category :

Pharmaceutical

No. of Pages : 109 Pages

In this report, the EMEA Therapeutic Drug Monitoring market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Therapeutic Drug Monitoring for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Therapeutic Drug Monitoring market competition by top manufacturers/players, with Therapeutic Drug Monitoring sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
F. Hoffmann-La Roche AG
Siemens Healthcare
Thermo Fisher Scientific
Bio-Rad Laboratories Inc.
Danaher Corporation
...

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Blood Test
Urine Test
Saliva Test
Other Test

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Therapeutic Drug Monitoring for each application, including
Hospital Laboratories
Commercial/Private Laboratories
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

EMEA (Europe, Middle East and Africa) Therapeutic Drug Monitoring Market Report 2017
1 Therapeutic Drug Monitoring Overview
1.1 Product Overview and Scope of Therapeutic Drug Monitoring
1.2 Classification of Therapeutic Drug Monitoring
1.2.1 EMEA Therapeutic Drug Monitoring Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Therapeutic Drug Monitoring Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Blood Test
1.2.4 Urine Test
1.2.5 Saliva Test
1.2.6 Other Test
1.3 EMEA Therapeutic Drug Monitoring Market by Application/End Users
1.3.1 EMEA Therapeutic Drug Monitoring Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Hospital Laboratories
1.3.3 Commercial/Private Laboratories
1.3.4 Others
1.4 EMEA Therapeutic Drug Monitoring Market by Region
1.4.1 EMEA Therapeutic Drug Monitoring Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Therapeutic Drug Monitoring (2012-2022)
1.5.1 EMEA Therapeutic Drug Monitoring Sales and Growth Rate (2012-2022)
1.5.2 EMEA Therapeutic Drug Monitoring Revenue and Growth Rate (2012-2022)

2 EMEA Therapeutic Drug Monitoring Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Therapeutic Drug Monitoring Market Competition by Players/Manufacturers
2.1.1 EMEA Therapeutic Drug Monitoring Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Therapeutic Drug Monitoring Revenue and Share by Players (2012-2017)
2.1.3 EMEA Therapeutic Drug Monitoring Sale Price by Players (2012-2017)
2.2 EMEA Therapeutic Drug Monitoring (Volume and Value) by Type/Product Category
2.2.1 EMEA Therapeutic Drug Monitoring Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Therapeutic Drug Monitoring Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Therapeutic Drug Monitoring Sale Price by Type (2012-2017)
2.3 EMEA Therapeutic Drug Monitoring (Volume) by Application
2.4 EMEA Therapeutic Drug Monitoring (Volume and Value) by Region
2.4.1 EMEA Therapeutic Drug Monitoring Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Therapeutic Drug Monitoring Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Therapeutic Drug Monitoring Sales Price by Region (2012-2017)

3 Europe Therapeutic Drug Monitoring (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Therapeutic Drug Monitoring Sales and Value (2012-2017)
3.1.1 Europe Therapeutic Drug Monitoring Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Therapeutic Drug Monitoring Revenue and Growth Rate (2012-2017)
3.2 Europe Therapeutic Drug Monitoring Sales and Market Share by Type
3.3 Europe Therapeutic Drug Monitoring Sales and Market Share by Application
3.4 Europe Therapeutic Drug Monitoring Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Therapeutic Drug Monitoring Sales Volume by Countries (2012-2017)
3.4.2 Europe Therapeutic Drug Monitoring Revenue by Countries (2012-2017)
3.4.3 Germany Therapeutic Drug Monitoring Sales and Growth Rate (2012-2017)
3.4.4 France Therapeutic Drug Monitoring Sales and Growth Rate (2012-2017)
3.4.5 UK Therapeutic Drug Monitoring Sales and Growth Rate (2012-2017)
3.4.6 Russia Therapeutic Drug Monitoring Sales and Growth Rate (2012-2017)
3.4.7 Italy Therapeutic Drug Monitoring Sales and Growth Rate (2012-2017)
3.4.8 Benelux Therapeutic Drug Monitoring Sales and Growth Rate (2012-2017)

4 Middle East Therapeutic Drug Monitoring (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Therapeutic Drug Monitoring Sales and Value (2012-2017)
4.1.1 Middle East Therapeutic Drug Monitoring Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Therapeutic Drug Monitoring Revenue and Growth Rate (2012-2017)
4.2 Middle East Therapeutic Drug Monitoring Sales and Market Share by Type
4.3 Middle East Therapeutic Drug Monitoring Sales and Market Share by Application
4.4 Middle East Therapeutic Drug Monitoring Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Therapeutic Drug Monitoring Sales Volume by Countries (2012-2017)
4.4.2 Middle East Therapeutic Drug Monitoring Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Therapeutic Drug Monitoring Sales and Growth Rate (2012-2017)
4.4.4 Israel Therapeutic Drug Monitoring Sales and Growth Rate (2012-2017)
4.4.5 UAE Therapeutic Drug Monitoring Sales and Growth Rate (2012-2017)
4.4.6 Iran Therapeutic Drug Monitoring Sales and Growth Rate (2012-2017)

5 Africa Therapeutic Drug Monitoring (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Therapeutic Drug Monitoring Sales and Value (2012-2017)
5.1.1 Africa Therapeutic Drug Monitoring Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Therapeutic Drug Monitoring Revenue and Growth Rate (2012-2017)
5.2 Africa Therapeutic Drug Monitoring Sales and Market Share by Type
5.3 Africa Therapeutic Drug Monitoring Sales and Market Share by Application
5.4 Africa Therapeutic Drug Monitoring Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Therapeutic Drug Monitoring Sales Volume by Countries (2012-2017)
5.4.2 Africa Therapeutic Drug Monitoring Revenue by Countries (2012-2017)
5.4.3 South Africa Therapeutic Drug Monitoring Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Therapeutic Drug Monitoring Sales and Growth Rate (2012-2017)
5.4.5 Egypt Therapeutic Drug Monitoring Sales and Growth Rate (2012-2017)
5.4.6 Algeria Therapeutic Drug Monitoring Sales and Growth Rate (2012-2017)

6 EMEA Therapeutic Drug Monitoring Manufacturers/Players Profiles and Sales Data
6.1 F. Hoffmann-La Roche AG
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Therapeutic Drug Monitoring Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 F. Hoffmann-La Roche AG Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Siemens Healthcare
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Therapeutic Drug Monitoring Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Siemens Healthcare Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Thermo Fisher Scientific
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Therapeutic Drug Monitoring Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Thermo Fisher Scientific Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Bio-Rad Laboratories Inc.
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Therapeutic Drug Monitoring Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Bio-Rad Laboratories Inc. Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Danaher Corporation
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Therapeutic Drug Monitoring Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Danaher Corporation Therapeutic Drug Monitoring Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
...

7 Therapeutic Drug Monitoring Manufacturing Cost Analysis
7.1 Therapeutic Drug Monitoring Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Therapeutic Drug Monitoring

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Therapeutic Drug Monitoring Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Therapeutic Drug Monitoring Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Therapeutic Drug Monitoring Market Forecast (2017-2022)
11.1 EMEA Therapeutic Drug Monitoring Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Therapeutic Drug Monitoring Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Therapeutic Drug Monitoring Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Therapeutic Drug Monitoring Price and Trend Forecast (2017-2022)
11.2 EMEA Therapeutic Drug Monitoring Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Therapeutic Drug Monitoring Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Therapeutic Drug Monitoring Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Therapeutic Drug Monitoring Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Therapeutic Drug Monitoring Sales Forecast by Type (2017-2022)
11.7 EMEA Therapeutic Drug Monitoring Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Therapeutic Drug Monitoring
Figure EMEA Therapeutic Drug Monitoring Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Therapeutic Drug Monitoring Sales Volume Market Share by Type (Product Category) in 2016
Figure Blood Test Product Picture
Figure Urine Test Product Picture
Figure Saliva Test Product Picture
Figure Other Test Product Picture
Figure EMEA Therapeutic Drug Monitoring Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Therapeutic Drug Monitoring by Application in 2016
Figure Hospital Laboratories Examples
Table Key Downstream Customer in Hospital Laboratories
Figure Commercial/Private Laboratories Examples
Table Key Downstream Customer in Commercial/Private Laboratories
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Therapeutic Drug Monitoring Market Size (Million USD) by Region (2012-2022)
Figure Europe Therapeutic Drug Monitoring Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Therapeutic Drug Monitoring Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Therapeutic Drug Monitoring Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Therapeutic Drug Monitoring Revenue (Million USD) Status and Forecast by Countries
Figure Africa Therapeutic Drug Monitoring Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Therapeutic Drug Monitoring Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Therapeutic Drug Monitoring Sales Volume and Growth Rate (2012-2022)
Figure EMEA Therapeutic Drug Monitoring Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Therapeutic Drug Monitoring Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Therapeutic Drug Monitoring Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Therapeutic Drug Monitoring Sales Share by Players (2012-2017)
Figure 2016 Therapeutic Drug Monitoring Sales Share by Players
Figure 2017 Therapeutic Drug Monitoring Sales Share by Players
Figure EMEA Therapeutic Drug Monitoring Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Therapeutic Drug Monitoring Revenue (Million USD) by Players (2012-2017)
Table EMEA Therapeutic Drug Monitoring Revenue Share by Players (2012-2017)
Table 2016 EMEA Therapeutic Drug Monitoring Revenue Share by Players
Table 2017 EMEA Therapeutic Drug Monitoring Revenue Share by Players
Table EMEA Therapeutic Drug Monitoring Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Therapeutic Drug Monitoring Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Therapeutic Drug Monitoring Sales Share by Type (2012-2017)
Figure Sales Market Share of Therapeutic Drug Monitoring by Type (2012-2017)
Figure EMEA Therapeutic Drug Monitoring Sales Market Share by Type (2012-2017)
Table EMEA Therapeutic Drug Monitoring Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Therapeutic Drug Monitoring Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Therapeutic Drug Monitoring by Type in 2016
Table EMEA Therapeutic Drug Monitoring Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Therapeutic Drug Monitoring Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Therapeutic Drug Monitoring Sales Share by Application (2012-2017)
Figure Sales Market Share of Therapeutic Drug Monitoring by Application (2012-2017)
Figure EMEA Therapeutic Drug Monitoring Sales Market Share by Application in 2016
Table EMEA Therapeutic Drug Monitoring Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Therapeutic Drug Monitoring Sales Share by Region (2012-2017)
Figure Sales Market Share of Therapeutic Drug Monitoring by Region (2012-2017)
Figure EMEA Therapeutic Drug Monitoring Sales Market Share in 2016
Table EMEA Therapeutic Drug Monitoring Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Therapeutic Drug Monitoring Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Therapeutic Drug Monitoring by Region (2012-2017)
Figure EMEA Therapeutic Drug Monitoring Revenue Market Share Regions in 2016
Table EMEA Therapeutic Drug Monitoring Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Therapeutic Drug Monitoring Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Therapeutic Drug Monitoring Revenue and Growth Rate (2012-2017)
Table Europe Therapeutic Drug Monitoring Sales (K Units) by Type (2012-2017)
Table Europe Therapeutic Drug Monitoring Market Share by Type (2012-2017)
Figure Europe Therapeutic Drug Monitoring Market Share by Type in 2016
Table Europe Therapeutic Drug Monitoring Sales (K Units) by Application (2012-2017)
Table Europe Therapeutic Drug Monitoring Market Share by Application (2012-2017)
Figure Europe Therapeutic Drug Monitoring Market Share by Application in 2016
Table Europe Therapeutic Drug Monitoring Sales (K Units) by Countries (2012-2017)
Table Europe Therapeutic Drug Monitoring Sales Market Share by Countries (2012-2017)
Figure Europe Therapeutic Drug Monitoring Sales Market Share by Countries (2012-2017)
Figure Europe Therapeutic Drug Monitoring Sales Market Share by Countries in 2016
Table Europe Therapeutic Drug Monitoring Revenue (Million USD) by Countries (2012-2017)
Table Europe Therapeutic Drug Monitoring Revenue Market Share by Countries (2012-2017)
Figure Europe Therapeutic Drug Monitoring Revenue Market Share by Countries (2012-2017)
Figure Europe Therapeutic Drug Monitoring Revenue Market Share by Countries in 2016
Figure Germany Therapeutic Drug Monitoring Sales (K Units) and Growth Rate (2012-2017)
Figure France Therapeutic Drug Monitoring Sales (K Units) and Growth Rate (2012-2017)
Figure UK Therapeutic Drug Monitoring Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Therapeutic Drug Monitoring Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Therapeutic Drug Monitoring Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Therapeutic Drug Monitoring Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Therapeutic Drug Monitoring Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Therapeutic Drug Monitoring Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Therapeutic Drug Monitoring Sales (K Units) by Type (2012-2017)
Table Middle East Therapeutic Drug Monitoring Market Share by Type (2012-2017)
Figure Middle East Therapeutic Drug Monitoring Market Share by Type (2012-2017)
Table Middle East Therapeutic Drug Monitoring Sales (K Units) by Applications (2012-2017)
Table Middle East Therapeutic Drug Monitoring Market Share by Applications (2012-2017)
Figure Middle East Therapeutic Drug Monitoring Sales Market Share by Application in 2016
Table Middle East Therapeutic Drug Monitoring Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Therapeutic Drug Monitoring Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Therapeutic Drug Monitoring Sales Volume Market Share by Countries in 2016
Table Middle East Therapeutic Drug Monitoring Revenue (Million USD) by Countries (2012-2017)
Table Middle East Therapeutic Drug Monitoring Revenue Market Share by Countries (2012-2017)
Figure Middle East Therapeutic Drug Monitoring Revenue Market Share by Countries (2012-2017)
Figure Middle East Therapeutic Drug Monitoring Revenue Market Share by Countries in 2016
Figure Saudi Arabia Therapeutic Drug Monitoring Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Therapeutic Drug Monitoring Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Therapeutic Drug Monitoring Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Therapeutic Drug Monitoring Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Therapeutic Drug Monitoring Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Therapeutic Drug Monitoring Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Therapeutic Drug Monitoring Sales (K Units) by Type (2012-2017)
Table Africa Therapeutic Drug Monitoring Sales Market Share by Type (2012-2017)
Figure Africa Therapeutic Drug Monitoring Sales Market Share by Type (2012-2017)
Figure Africa Therapeutic Drug Monitoring Sales Market Share by Type in 2016
Table Africa Therapeutic Drug Monitoring Sales (K Units) by Application (2012-2017)
Table Africa Therapeutic Drug Monitoring Sales Market Share by Application (2012-2017)
Figure Africa Therapeutic Drug Monitoring Sales Market Share by Application (2012-2017)
Table Africa Therapeutic Drug Monitoring Sales Volume (K Units) by Countries (2012-2017)
Table Africa Therapeutic Drug Monitoring Sales Market Share by Countries (2012-2017)
Figure Africa Therapeutic Drug Monitoring Sales Market Share by Countries (2012-2017)
Figure Africa Therapeutic Drug Monitoring Sales Market Share by Countries in 2016
Table Africa Therapeutic Drug Monitoring Revenue (Million USD) by Countries (2012-2017)
Table Africa Therapeutic Drug Monitoring Revenue Market Share by Countries (2012-2017)
Figure Africa Therapeutic Drug Monitoring Revenue Market Share by Countries (2012-2017)
Figure Africa Therapeutic Drug Monitoring Revenue Market Share by Countries in 2016
Figure South Africa Therapeutic Drug Monitoring Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Therapeutic Drug Monitoring Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Therapeutic Drug Monitoring Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Therapeutic Drug Monitoring Sales (K Units) and Growth Rate (2012-2017)
Table F. Hoffmann-La Roche AG Therapeutic Drug Monitoring Basic Information List
Table F. Hoffmann-La Roche AG Therapeutic Drug Monitoring Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche AG Therapeutic Drug Monitoring Sales (K Units) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche AG Therapeutic Drug Monitoring Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche AG Therapeutic Drug Monitoring Revenue Market Share in EMEA (2012-2017)
Table Siemens Healthcare Therapeutic Drug Monitoring Basic Information List
Table Siemens Healthcare Therapeutic Drug Monitoring Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Siemens Healthcare Therapeutic Drug Monitoring Sales (K Units) and Growth Rate (2012-2017)
Figure Siemens Healthcare Therapeutic Drug Monitoring Sales Market Share in EMEA (2012-2017)
Figure Siemens Healthcare Therapeutic Drug Monitoring Revenue Market Share in EMEA (2012-2017)
Table Thermo Fisher Scientific Therapeutic Drug Monitoring Basic Information List
Table Thermo Fisher Scientific Therapeutic Drug Monitoring Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific Therapeutic Drug Monitoring Sales (K Units) and Growth Rate (2012-2017)
Figure Thermo Fisher Scientific Therapeutic Drug Monitoring Sales Market Share in EMEA (2012-2017)
Figure Thermo Fisher Scientific Therapeutic Drug Monitoring Revenue Market Share in EMEA (2012-2017)
Table Bio-Rad Laboratories Inc. Therapeutic Drug Monitoring Basic Information List
Table Bio-Rad Laboratories Inc. Therapeutic Drug Monitoring Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bio-Rad Laboratories Inc. Therapeutic Drug Monitoring Sales (K Units) and Growth Rate (2012-2017)
Figure Bio-Rad Laboratories Inc. Therapeutic Drug Monitoring Sales Market Share in EMEA (2012-2017)
Figure Bio-Rad Laboratories Inc. Therapeutic Drug Monitoring Revenue Market Share in EMEA (2012-2017)
Table Danaher Corporation Therapeutic Drug Monitoring Basic Information List
Table Danaher Corporation Therapeutic Drug Monitoring Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Danaher Corporation Therapeutic Drug Monitoring Sales (K Units) and Growth Rate (2012-2017)
Figure Danaher Corporation Therapeutic Drug Monitoring Sales Market Share in EMEA (2012-2017)
Figure Danaher Corporation Therapeutic Drug Monitoring Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Therapeutic Drug Monitoring
Figure Manufacturing Process Analysis of Therapeutic Drug Monitoring
Figure Therapeutic Drug Monitoring Industrial Chain Analysis
Table Raw Materials Sources of Therapeutic Drug Monitoring Major Manufacturers in 2016
Table Major Buyers of Therapeutic Drug Monitoring
Table Distributors/Traders List
Figure EMEA Therapeutic Drug Monitoring Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Therapeutic Drug Monitoring Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Therapeutic Drug Monitoring Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Therapeutic Drug Monitoring Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Therapeutic Drug Monitoring Sales Market Share Forecast by Region (2017-2022)
Table EMEA Therapeutic Drug Monitoring Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Therapeutic Drug Monitoring Revenue Market Share Forecast by Region (2017-2022)
Table Europe Therapeutic Drug Monitoring Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Therapeutic Drug Monitoring Sales Market Share Forecast by Countries (2017-2022)
Table Europe Therapeutic Drug Monitoring Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Therapeutic Drug Monitoring Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Therapeutic Drug Monitoring Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Therapeutic Drug Monitoring Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Therapeutic Drug Monitoring Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Therapeutic Drug Monitoring Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Therapeutic Drug Monitoring Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Therapeutic Drug Monitoring Sales Market Share Forecast by Countries (2017-2022)
Table Africa Therapeutic Drug Monitoring Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Therapeutic Drug Monitoring Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Therapeutic Drug Monitoring Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Therapeutic Drug Monitoring Sales Market Share Forecast by Type (2017-2022)
Table EMEA Therapeutic Drug Monitoring Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Therapeutic Drug Monitoring Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *